These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1139 related articles for article (PubMed ID: 17376795)
1. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Sud S; Klein GJ; Skanes AC; Gula LJ; Yee R; Krahn AD Europace; 2007 May; 9(5):312-8. PubMed ID: 17376795 [TBL] [Abstract][Full Text] [Related]
2. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666 [TBL] [Abstract][Full Text] [Related]
3. The intravenous adenosine test: a new test for the identification of bradycardia pacing indications? A pilot study in subjects with bradycardia pacing indications, vasovagal syncope and controls. Parry SW; Chadwick T; Gray JC; Bexton RS; Tynan M; Bourke JP; Nath S QJM; 2009 Jul; 102(7):461-8. PubMed ID: 19468041 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M; Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153 [TBL] [Abstract][Full Text] [Related]
5. Analysis of rhythm variation during spontaneous cardioinhibitory neurally-mediated syncope. Implications for RDR pacing optimization: an ISSUE 2 substudy. Brignole M; Sutton R; Wieling W; Lu SN; Erickson MK; Markowitz T; Grovale N; Ammirati F; Benditt DG Europace; 2007 May; 9(5):305-11. PubMed ID: 17400603 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of empirical cardiac pacing in syncope of unknown cause. Rattes MF; Klein GJ; Sharma AD; Boone JA; Kerr C; Milstein S CMAJ; 1989 Feb; 140(4):381-5. PubMed ID: 2914259 [TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope. Bortnik M; Occhetta E; Dell'Era G; Secco GG; Degiovanni A; Plebani L; Marino P J Cardiovasc Med (Hagerstown); 2012 Apr; 13(4):242-5. PubMed ID: 22367575 [TBL] [Abstract][Full Text] [Related]
8. [Long-term results of pacemaker therapy in hypersensitive carotid sinus syndrome]. Waldecker B; Frees U; Brachmann J; Thorspecken R; Kübler W Z Kardiol; 1989 Jul; 78(7):453-8. PubMed ID: 2672654 [TBL] [Abstract][Full Text] [Related]
9. An implantable loop recorder study of highly symptomatic vasovagal patients: the heart rhythm observed during a spontaneous syncope is identical to the recurrent syncope but not correlated with the head-up tilt test or adenosine triphosphate test. Deharo JC; Jego C; Lanteaume A; Djiane P J Am Coll Cardiol; 2006 Feb; 47(3):587-93. PubMed ID: 16458141 [TBL] [Abstract][Full Text] [Related]
10. Clinical predictors of cardiac events in patients with isolated syncope and negative electrophysiologic study. Da Costa A; Gulian JL; Romeyer-Bouchard C; Messier M; Zarqane N; Samuel B; Khiel A; Isaaz K Int J Cardiol; 2006 Apr; 109(1):28-33. PubMed ID: 15975670 [TBL] [Abstract][Full Text] [Related]
11. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Brignole M; Sutton R; Menozzi C; Garcia-Civera R; Moya A; Wieling W; Andresen D; Benditt DG; Vardas P; Eur Heart J; 2006 May; 27(9):1085-92. PubMed ID: 16569653 [TBL] [Abstract][Full Text] [Related]
12. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials. Sheldon R; Connolly S; Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266 [TBL] [Abstract][Full Text] [Related]
13. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study. Occhetta E; Bortnik M; Audoglio R; Vassanelli C; Europace; 2004 Nov; 6(6):538-47. PubMed ID: 15519257 [TBL] [Abstract][Full Text] [Related]
15. The expectation effect and cardiac pacing for refractory vasovagal syncope. Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of presyncope in patients monitored for assessment of syncope. Krahn AD; Klein GJ; Yee R; Skanes AC; Am Heart J; 2001 May; 141(5):817-21. PubMed ID: 11320372 [TBL] [Abstract][Full Text] [Related]
17. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G; Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504 [TBL] [Abstract][Full Text] [Related]
18. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up. Palmisano P; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S Europace; 2012 Jul; 14(7):1038-43. PubMed ID: 22247273 [TBL] [Abstract][Full Text] [Related]